The Placebo Response in the Treatment of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis

@article{Cho2005ThePR,
  title={The Placebo Response in the Treatment of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis},
  author={Hyong Jin Cho and Matthew Hotopf and Simon Wessely},
  journal={Psychosomatic Medicine},
  year={2005},
  volume={67},
  pages={301-313}
}
Objective: The placebo response is conventionally asserted to be high in chronic fatigue syndrome (CFS) because of the latter’s subjective nature and obscure pathogenesis, but no systematic review of placebo responses has been undertaken. We report such a study. Patient expectation is known to be important in the placebo response. It is also known that CFS patients attending specialist clinics often have strong physical attributions regarding causation and hence skepticism about psychological… Expand
Placebo response in trials of drug treatments for cancer-related fatigue: a systematic review, meta-analysis and meta-regression
TLDR
There is some evidence, based on trials with small samples, that the PR in trials testing drugs for CRF is non-trivial in size and statistically significant. Expand
The Effect of Acclydine in Chronic Fatigue Syndrome: A Randomized Controlled Trial
TLDR
A randomized, placebo-controlled, double-blind clinical trial to measure the IGF1 and IGF binding protein (IGFBP) 3 status of CFS patients compared to age- and gender-matched neighborhood controls found no differences in IGF1 status. Expand
Placebo eff ects in psychiatry: mediators and moderators.
TLDR
It is suggested that predictors of the placebo response are still to be discovered, the response probably has more than one mediator, and that different and distinct moderators are probably what cause the placebo responded within psychiatry and beyond. Expand
Identifying placebo responders and predictors of response in osteoarthritis: a protocol for individual patient data meta-analysis
TLDR
The results of this study may be useful for pharmaceutical companies, who could improve the design of their studies in order to separate the specific treatment from the non-specific contextual (i.e. placebo) effects. Expand
Cognitive behaviour therapy for chronic fatigue syndrome in adults.
TLDR
CBT is effective in reducing the symptoms of fatigue at post-treatment compared with usual care, and may be more effective in reduced fatigue symptoms compared with other psychological therapies, according to a review of 15 randomised controlled trials. Expand
Placebo Responses and Placebo Effects in Functional Gastrointestinal Disorders
TLDR
It is concluded that, contrary to common belief and discussion, the placebo effect seen in RCT in FGD is not specifically high and extraordinary as compared to other comparable disorders, and very few predictors have yet been identified that determine its effect size. Expand
Listening to placebo in clinical trials for female sexual dysfunction.
  • A. Bradford
  • Psychology, Medicine
  • The journal of sexual medicine
  • 2013
TLDR
P Procedural and methodological factors are likely to contribute to placebo response in trials for FSD, though additional research is needed to clarify these effects. Expand
Clinical methodology and its implications for the study of therapeutic interventions for chronic fatigue syndrome: a commentary.
TLDR
The role of clinical methodology in the study of the therapeutics of CFS is not trivial, and may confound the understanding of pragmatic recommendations for treatment. Expand
The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials
TLDR
The placebo effect is effective in the treatment of OA, especially for pain, stiffness and self-reported function, and the size of this effect is influenced by the strength of the active treatment, the baseline disease severity, the route of delivery and the sample size of the study. Expand
Does methylphenidate reduce the symptoms of chronic fatigue syndrome?
TLDR
Methylphenidate at a dose of 2 x 10 mg/day is significantly better than placebo in relieving fatigue and concentration disturbances in a minority of chronic fatigue syndrome patients. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 124 REFERENCES
A randomised, controlled, triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome.
TLDR
There is weak but equivocal evidence that the effects of homeopathic medicine are superior to placebo and results suggest that there may be nonspecific benefits from the homeopathic consultation. Expand
Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome.
TLDR
The results suggest that terfenadine is unlikely to be of clinical benefit in treating CFS symptoms, and no therapeutic benefit could be detected in terms of symptom amelioration, improved physical or social functioning, health perceptions, or mental health. Expand
Interventions for the treatment and management of chronic fatigue syndrome: a systematic review.
TLDR
To assess the effectiveness of all interventions that have been evaluated for use in the treatment or management of CFS in adults or children, 350 studies initially identified demonstrated mixed results in terms of effectiveness. Expand
Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome
TLDR
Fluoxetine in a 20 mg daily dose does not have a beneficial effect on any characteristic of CFS, which suggests that processes underlying the presentation of depressive symptoms in CFS may differ from those in patients with major depressive disorder. Expand
Placebo response in studies of major depression: variable, substantial, and growing.
TLDR
The response to placebo in published trials of antidepressant medication for MDD is highly variable and often substantial and has increased significantly in recent years, as has the response to medication. Expand
The treatment of chronic fatigue syndrome: science and speculation.
TLDR
Future treatment studies should examine differential response rates for possible subtypes of the disorder, evaluate the extent of any synergistic effects between therapies, and employ a wide range of biologic and psychologic parameters as markers of treatment response. Expand
A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome.
TLDR
Low-dose fludrocortisone does not provide sufficient benefit to be evident in a preliminary blinded trial of unselected patients with chronic fatigue syndrome, and evidence of marked functional impairments is found. Expand
Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome
TLDR
The data support the hypothesis of reduced sympathetic drive, although an alternative hypothesis of pain alleviation is also possible, and no evidence for this was found, suggesting that CFS is not an illness due to patients' being overly suggestible. Expand
A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome.
TLDR
Immunomodulatory treatment with immunoglobulin is effective in a significant number of patients with CFS, a finding that supports the concept that an immunologic disturbance may be important in the pathogenesis of this disorder. Expand
Placebos, Placebo Effect, and the Response to the Healing Situation: The Evolution of a Concept
TLDR
This work presents the historical changes of the concept of placebo and the ethical issues raised by their use, and suggests that progress in this area may promote useful clinical applications, enabling physicians to broaden their perspectives on the healing process. Expand
...
1
2
3
4
5
...